Controlled release metformin formulations

US8475841B2 · kind B2 · utility

Assignee

• Andrx Labs, LLC · US

Inventors

• Xiu Xiu Cheng · Pembroke Pines, US
• Steve Jan · Coral Springs, US
• Joseph Chou · Coral Springs, US
• Chih-Ming Chen · Taipei, TW

Key dates

• Filing date: Mar 21, 2011
• Grant date: Jul 2, 2013
• Expiry date: Mar 21, 2031

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K9/2886
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Sustained release pharmaceutical formulations comprising an antihyperglycemic drug or a pharmaceutically acceptable salt thereof are disclosed. The formulations provide therapeutic plasma levels of the antihyperglycemic drug to a human patient over a 24 hour period after administration.